Torrent Pharmaceuticals Limited Reports Zero Observations in USFDA Inspection
Torrent Pharmaceuticals Limited announced the conclusion of a USFDA inspection at its Bileshwarpura (Oncology) facility. The inspection took place from April 6, 2026, to April 10, 2026, and resulted in zero observations.TORNTPHARM Stock Price Movement
Today, Torrent Pharmaceuticals Limited shares edged higher to close at ₹4155.2, climbing 1.26% for the session. The stock settled today on a total volume of 354,702 shares.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.